FDA Clears 31 New Molecular Entities In 2004, Up Ten From Previous Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer's Lyrica (pregabalin) is the final NME of the year. Over 20% of the approvals came in the last two weeks of December.